MASH Imaging: Translational Role of Quantitative Imaging in MASH Clinical Trials
Synthetic Medical Images Risks and Opportunities
Metrology for MRI: An Update from NIST
Digital Twins
Adopting Photon-counting CT for Clinical Trials: Promises, Pitfalls, and Pathways
Post-Treatment Imaging of Brain Tumor RANO 2.0
Radiopharmaceuticals & Future Trends: Highlighting FAPI and Granzyme B Imaging
Advancing Oncology Imaging Beyond RECIST 1.1
Imaging-Based Tools to Enhance Signals of Efficacy in Early Stages of Oncology Clinical Development
Multimodal and Multiparametric Molecular Imaging in Fibroproliferative Diseases
ICH GCP E6 (R3) and Potential Requirements for Imaging in Clinical Trials
Granzyme B PET Imaging
Whole Body MRI in Multiple Myeloma and Prostate Cancer
What’s In Your Data
New Developments in Quantitative Osteoporosis Imaging
Photon CT
Imaging in Rheumatic Disease Trials
Statistical Considerations for Studies Validating Imaging Biomarkers
Applications of Artificial Intelligence: Machine Learning in Imaging Trials
Focused Ultrasound Blood Brain Barrier Disruption
Interested in PINTaD Meetings prior to 2013?
Additional materials and presentations may be downloaded below.